INS and metabolic syndrome: To date, multiple clinical trials have demonstrated the beneficial effects of coenzyme Q10 in patients with cardiovascular disease and hypertension [11, 12], and one study of patients with metabolic syndrome found that an 8-week coenzyme Q10 treatment course had beneficial effects on serum insulin levels and HOMA-IR values [13].